57.92 USD
↗ 0.44 (0.76%)PRE MARKET (AS OF 08:15 AM EDT)
Royalty Pharma plc Class A Ordinary Shares
RPRXNASDAQ • USD
Market: OPEN
Royalty Pharma plc Class A Ordinary Shares (RPRX) is currently trading at $57.92. Technicals currently rate "Buy" while our fundamental analysis reads "Neutral". Notable factors include a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Aug 4, 2026.
Open?$57.35
High?$58.89
Low?$57.35
Prev. Close?$57.48
Volume?1.6K
Avg. Volume?3.0M
VWAP?$58.19
Rel. Volume?0.00x
Bid / Ask
Bid?$54.11 × 100
Ask?$60.10 × 100
Spread?$5.99
Midpoint?$57.11
Valuation & Ratios
Market Cap?25.5B
Shares Out?443.3M
Float?435.9M
Float %?98.3%
P/E Ratio?30.80
P/B Ratio?3.70
EPS?$1.87
Dividend?2.89%
Ex-Dividend?2026-08-14
News
Profile
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
Themes
Employees
100
Market Cap
25.3B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2020-06-16
Address
110 EAST 59TH STREET
NEW YORK, NY 10022
Phone: (212) 883-0200
NEW YORK, NY 10022
Phone: (212) 883-0200
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?40
Z-Score?41
Momentum?73
Short Sent.?78
Piotroski F-Score?4/9Mixed
Altman Z-Score?2.17Grey
Confidence?74%Moderate
Short InterestModerate
Short % of Float?2.78%Low
Short Interest?12.1M
Days to Cover?4.4
Free Float435.9M
Avg Daily Volume2.7M
Settlement Date2026-07-15
Financial Health
Current Ratio?2.66Strong
Quick Ratio?2.66Strong
Cash Ratio?1.09Strong
Debt/Equity?1.30Moderate
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score40/100
P/E?30.8PRICEY▾
Peers100
S&P31
P/B?3.70FAIR▾
Peers100
S&P47
P/S?10.44HIGH▾
Peers100
S&P8
P/FCF?N/A▾
EV/EBITDA?23.0HIGH▾
Peers100
S&P18
EV/Sales?13.88HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?12.0%STRONG▾
Peers50
S&P43
ROA?4.2%FAIR▾
Peers50
S&P38
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$33.9B
Fundamentals ratios updated end of day